Literature DB >> 29441569

Epidemiologic associations of HPV-positive oropharyngeal cancer and (pre)cancerous cervical lesions.

M M Rietbergen1, A A J D van Bokhoven1, B I Lissenberg-Witte2, D A M Heideman3, C R Leemans1, R H Brakenhoff1, E Bloemena3,4.   

Abstract

Human papillomavirus (HPV)-induced oropharyngeal squamous cell carcinoma (OPSCC) remains increasing worldwide. We aimed to investigate if the HPV-prevalence of OPSCC in the Netherlands is rising as well, also in female patients. In addition, we evaluated the association between HPV-positive OPSCC and suspicious Pap results of the cervix in these female patients. Patients with OPSCC treated in the period 2000-2015 at the VU University Medical Center Amsterdam, were included (n = 926). The presence of an oncogenic HPV infection was determined by p16-immunostaining, followed by a high-risk HPV general primer 5+/6+ DNA PCR on the p16-immunopositive cases. A review of pathology reports in all female patients (n = 305) was undertaken to identify cytological signs of HPV-related (pre)cancer of the cervix. In total 281 of 926 (30.3%) OPSCCs were HPV-positive. Moreover, a significant increase in the prevalence of HPV-positive OPSCCs was observed from 14.0% in 2000 to 48.1% in 2015 (p < 0.001). Among the female patients with an HPV-positive OPSSC (n = 70), the results of cervical smears were available in 56 of 70 patients (80.0%). Of the female patients with HPV-positive OPSCC, 9 of 56 (16.1%) patients had a vaginal cuff Papanicolaou (Pap) test ≥3b in their medical history compared to 7 of 168 (4.2%) in the HPV-negative group (p = 0.003). In conclusion, a continuous increase in the HPV-attributable fraction of OPSCC was demonstrated in the period 2000-2015 in the Amsterdam region. HPV-positive OPSCC has a significant association with a history of suspicious Pap results of the cervix in female patients.
© 2018 UICC.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29441569     DOI: 10.1002/ijc.31315

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Population-Based Analysis of Trends in Incidence and Survival of Human Papilloma Virus-Related Oropharyngeal Cancer in a Low-Burden Region of Southern Europe.

Authors:  Jordi Rubió-Casadevall; Elna Ciurana; Montserrat Puigdemont; Arantza Sanvisens; Jordi Marruecos; Josefina Miró; Antoni Urban; Rosa-Lisset Palhua; Ferran Martín-Romero; Maria Rosa Ortiz-Duran; Rafael Marcos-Gragera
Journal:  Int J Environ Res Public Health       Date:  2022-04-15       Impact factor: 4.614

Review 2.  Ubiquitin Carboxyl-Terminal Hydrolases and Human Malignancies: The Novel Prognostic and Therapeutic Implications for Head and Neck Cancer.

Authors:  Chao Rong; Ran Zhou; Shan Wan; Dan Su; Shou-Li Wang; Jochen Hess
Journal:  Front Oncol       Date:  2021-01-29       Impact factor: 6.244

3.  Low Rates of Dual-Site and Concordant Oral-Cervical Human Papillomavirus Infections and Cancers: A Systematic Review.

Authors:  Kelsey H Jordan; Chloe M Beverly Hery; Xiaochen Zhang; Electra D Paskett
Journal:  Front Oncol       Date:  2022-03-29       Impact factor: 6.244

4.  Association of human papillomavirus related squamous cell carcinomas of the oropharynx and cervix.

Authors:  Malak Jamal Gazzaz; Caroline Jeffery; Daniel O'Connell; Jeffery Harris; Hadi Seikaly; Vincent Biron
Journal:  Papillomavirus Res       Date:  2019-10-16

Review 5.  HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management.

Authors:  Matt Lechner; Jacklyn Liu; Liam Masterson; Tim R Fenton
Journal:  Nat Rev Clin Oncol       Date:  2022-02-01       Impact factor: 65.011

6.  Targeted Therapy With PI3K and FGFR Inhibitors on Human Papillomavirus Positive and Negative Tonsillar and Base of Tongue Cancer Lines With and Without Corresponding Mutations.

Authors:  Stefan Holzhauser; Nicole Wild; Mark Zupancic; Ramona G Ursu; Cinzia Bersani; Anders Näsman; Ourania N Kostopoulou; Tina Dalianis
Journal:  Front Oncol       Date:  2021-05-11       Impact factor: 6.244

7.  Exposure to Microbial Metabolite Butyrate Prolongs the Survival Time and Changes the Growth Pattern of Human Papillomavirus 16 E6/E7-Immortalized Keratinocytes in Vivo.

Authors:  Mengtao Li; Eva M McGhee; Lauryn Shinno; Kellie Lee; Yi-Ling Lin
Journal:  Am J Pathol       Date:  2021-06-29       Impact factor: 4.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.